Abstract
Over a one-year period, 95 children and adolescents presenting with epigastric pain and/or vomiting, and without associated risk factors for development of peptic disease, underwent endoscopic antral biopsies for pathologic diagnosis and to detect presence of Campylobacterss. pylori (C. pylori). Additional biopsies of the esophagus, stomach, and duodenum were obtained for histologic evaluation. C. pylori was identified in 16 patients (16.8%), all of whom had evidence of acute and/or chronic gastritis. Significant discriminating factors between C. pylori-positive and -negative subjects included age at presentation (positive vs negative=14.6 vs 9.9 years, P<0.01, biopsy-confirmed gastritis (100% vs 30.4%, P<0.001), and diagnosis of duodenitis alone (0% vs 46.8%, P<0.001). Risk for bacterial colonization was significantly higher in the presence of endoscopic gastritis (P<0.001). Among C. pylori-positive patients, none responded to standard antiulcer therapy (H2-receptor antagonists, antacids). Symptomatic and histologic remission was achieved utilizing combined therapy with bismuth subsalicylate and antibiotics. Seven of 79 C. pylori-negative patients with biopsyproven gastritis who responded poorly to antisecretory therapy had the organism identified in follow-up antral biopsies; these patients improved clinically following treatment for C. pylori. These data suggest that C. pylori is a significant factor in the etiology of upper gastrointestinal tract inflammatory disease in pediatrics, and presence of the organism should be evaluated, particularly in children with evidence of acute and/or chronic gastritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rauws EA, Langenberg W, Houthoff H, et al:Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 94:33–40, 1988
Buck GE, Gourley WK, Lee WK, et al: Relation ofCampylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 153:664–669, 1986
Barthel JS, Westblom TU, Havey AD, et al: Gastritis andCampylobacter pylori in healthy asymptomatic volunteers. Arch Intern Med 148:1149–1151, 1988
Drumm B, O'Brien A, Cutz E, Sherman P:Campylobacter pylori-associated primary gastritis in children. Pediatrics 80:192–194, 1987
Drumm B, Sherman P, Cutz E, Karmali M: Association ofCampylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 316:1557–1561, 1987
Czinn SJ, Carr H: Rapid diagnosis ofCampylobacter pyloridis-associated gastritis. J Pediatr 110:569–570, 1987
Kilbridge PM, Dahms BB, Czinn SJ:Campylobacter pylori-associated gastritis and peptic ulcer disease in children. Am J Dis Child 142:1149–1152, 1988
Price AB, Levi J, Dolby JM, et al:Campylobacter pyloridis in peptic ulcer disease: Microbiology, pathology and scanning electron microscopy. Gut 26:183–1188, 1985
Whitehead R: Mucosal biopsy of the gastrointestinal tract.In Major Problems in Pathology, Vol. 3, 3rd ed. JL Bennington (eds). Philadelphia, WB Saunders, 1985, pp 128–135
Gilman RH, Leon-Barua R, Kock J, et al: Rapid identification of pyloricCampylobacter in Peruvians with gastritis. Dig Dis Sci 31:1089–1095, 1986
Bauer J, Ackermann PG, Gelson T: Clinical Laboratory Methods, 8th ed. St Louis, C.V. Mosby, 1974
McNulty CAM, Wise R: Rapid diagnosis ofCampylobacter-associated gastritis. Lancet 1:1443–1444, 1985
Owen R, Martin SR, Berman P: Rapid urea hydrolysis by gastricCampylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1:111, 1985
Skirrow MB:Campylobacter enteritis: A “new” disease. Br Med J 2:9–11, 1977
Jawetz E, Melnick JL, Adelberg EA: 1987 Review of Medical Microbiology, 17th ed. Norwalk, Connecticut, Appleton-Lange Company, 1987
Sivrala M, Iskoski M, Varis K, Keickil M: Prevalence of gastritis in a rural population: Biopsy study of subjects studied at random. Scand J Gastroenterol 3:211–215, 1968
Jones DM, Eldridge J, Fox A, et al: Antibody to the gastricCampylobacter-like organism (“Campylobacter pyloridis”)—clinical coordination and distribution in the normal population. J Med Microbiol 22:57–62, 1986
Graham DY, Klein PD, Opekun AR, et al: Epidemiology ofCampylobacter pyloridis infections. Gastroenterology 92:A1411, 1988
Marshall BJ, Armstrong JA, McGeehie DB, Glancy RJ: Attempts to fulfill Koch's postulates for pyloric campylobacter. Med J Aust 142:443–448, 1985
Marshall BJ, McGeechie DB, Rogers PA, Glancy RJ: PyloricCampylobacter infection and gastroduodenal disease. Med J Aust 142:439–442, 1985
Elta G, Kern S, Nostrant T, Appleman H:Campylobacter-like organisms in erosive gastroduodenitis. Gastroenterology 92:1382, 1987
Slomiany BL, Bilski J, Sarosiek J, et al:Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 144:307–314, 1987
Rosenthal LE, Mobloy HLT, Cortesia MJ, Smoot D: Characterization of urease fromCampylobacter pylori: Possible therapeutic role of urease inhibitors. Am J Gastroenterol 92:934, 1987
Hui Wh, Lam SK, Chau PY, et al: Persistence ofCampylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 32:1255–1260, 1987
Hazell SL, Hennessy WB, Borody T, et al:Campylobacter pyloridis gastritis: II. Distribution of bacteria and associated inflammation in gastroduodenal environment. Am J Gastroenterol 82:297–301, 1987
Peterson WL, Lee EL, Feldman M: GastricCampylobacter-like organisms in healthy humans. Correlation with endoscopic appearance and mucosal histology. Gastroenterology 90:1585, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glassman, M.S., Schwarz, S.M., Medow, M.S. et al. Campylobacter pylori-related gastrointestinal disease in children. Digest Dis Sci 34, 1501–1504 (1989). https://doi.org/10.1007/BF01537100
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01537100